Cary Claiborne
Biotech executive focused on addiction medicine and CEO of Adial Pharmaceuticals, with prior CFO roles at Indivior, Sucampo, and Osiris and a background taking companies public.
Best podcasts with Cary Claiborne
Ranked by the Snipd community
Mar 6, 2026 • 14min
Adial CEO Cary Claiborne on Treating Alcohol Addiction with Genetics
Cary Claiborne, biotech CEO who shifted from finance to addiction medicine after a personal loss. He discusses a genetically targeted, low-dose repurposed therapy to curb alcohol cravings. They cover a simple cheek‑swab diagnostic, AI-led trial design, market and reimbursement implications, and potential expansion into other impulse-driven disorders.
